Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China.
Division of Gastroenterology and Hepatology, Department of Medicine, National University Hospital, National University of Singapore, Singapore.
Clin Gastroenterol Hepatol. 2022 Feb;20(2):372-380.e2. doi: 10.1016/j.cgh.2020.10.014. Epub 2020 Oct 14.
BACKGROUND & AIMS: Second forward view (SFV) examination of the right colon (RC) in colonoscopy was suggested to improve the adenoma detection rate (ADR), but multicenter data to inform its routine use remain limited. We performed an international multicenter randomized trial comparing SFV vs a standard single forward view examination of the RC on adenoma detection.
Asymptomatic individuals undergoing screening or surveillance colonoscopies from 6 Asia Pacific regions were invited for study. A forward view examination of the RC was first performed in all patients, followed by randomization at the hepatic flexure to either SFV examination of the RC and standard withdrawal examination from the hepatic flexure to rectum, or a standard withdrawal colonoscopy (SWC) examination from the hepatic flexure to rectum. The primary outcome was RC ADR.
Between 2016 and 2019, there were 1011 patients randomized (SFV group, 502 patients; SWC group, 509 patients). Forty-five endoscopists performed the colonoscopies. The RC ADR was significantly higher in the SFV group than in the SWC group (27.1% vs 21.6%; P = .042). The whole-colon ADR was high in both groups (49.0% vs 45.0%; P =.201). The SFV examination identified 58 additional adenomas in 49 patients (9.8%), leading to a change in surveillance recommendations in 15 patients (3.0%). The median overall withdrawal time was 1.5 minutes longer in the SFV group (12.0 vs 10.5 min; P < .001). Older age, male sex, ever smoking, and longer RC withdrawal time were independent predictors of right-sided adenoma detection.
In this multicenter trial, SFV examination significantly increased the RC ADR in screening and surveillance colonoscopies. Routine RC SFV examination should be considered. ClinicalTrials.gov ID: NCT03121495.
结肠镜检查时对右半结肠(RC)进行第二次前视(SFV)检查被认为可以提高腺瘤检出率(ADR),但关于其常规应用的多中心数据仍有限。我们进行了一项国际多中心随机试验,比较了 SFV 与 RC 的标准单前视检查在腺瘤检出方面的差异。
我们邀请了来自亚太地区 6 个地区的无症状个体参加筛查或监测结肠镜检查。所有患者首先进行 RC 的前视检查,然后在肝曲处随机分为 SFV 检查 RC 和标准撤回检查从肝曲到直肠,或从肝曲到直肠的标准撤回结肠镜检查(SWC)检查。主要结局是 RC 的 ADR。
2016 年至 2019 年间,共有 1011 例患者被随机分组(SFV 组 502 例,SWC 组 509 例)。45 名内镜医生进行了结肠镜检查。SFV 组的 RC ADR 明显高于 SWC 组(27.1%比 21.6%;P=0.042)。两组全结肠 ADR 均较高(49.0%比 45.0%;P=0.201)。SFV 检查在 49 例患者中发现了 58 个额外的腺瘤(9.8%),导致 15 例(3.0%)改变了监测建议。SFV 组的总退出时间中位数延长了 1.5 分钟(12.0 比 10.5 分钟;P<0.001)。年龄较大、男性、吸烟史和较长的 RC 退出时间是右半结肠腺瘤检出的独立预测因素。
在这项多中心试验中,SFV 检查显著提高了筛查和监测结肠镜检查中 RC 的 ADR。应考虑常规进行 RC SFV 检查。临床试验注册号:NCT03121495。